Does Ozempic Work for Weight Loss? Exploring the Benefits and Considerations

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, originally developed to help people with type 2 diabetes control blood sugar levels. In recent years, clinical research has demonstrated that semaglutide also produces significant weight loss in individuals with obesity, regardless of diabetes status. This dual mechanism has made it one of the most studied weight management medications in modern medicine.

How Semaglutide Supports Weight Loss

Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone your body naturally produces after eating. This hormone signals your brain that you are full, which reduces hunger and decreases the amount of food you consume throughout the day. Additionally, semaglutide slows gastric emptying—the rate at which food moves from your stomach to your small intestine—which extends feelings of fullness between meals.

The medication also influences appetite-regulating centers in your brain, helping many people experience fewer cravings and reduced food preoccupation. By lowering both hunger signals and calorie intake simultaneously, semaglutide creates an environment where sustainable weight loss becomes achievable without extreme dietary restriction. This multi-pathway approach explains why many people find adherence to lifestyle changes easier while taking the medication.

Clinical Evidence: What Research Shows About Semaglutide Effectiveness

The STEP trials, a series of large clinical studies involving over 4,500 participants, examined semaglutide's weight loss potential across different patient populations. Participants receiving the highest maintenance dose lost an average of 15% of their body weight over 68 weeks, compared to approximately 2.6% weight loss in the placebo group. These results held true whether or not participants had a history of type 2 diabetes, demonstrating broad effectiveness.

Beyond weight loss numbers, clinical trials documented improvements in blood pressure, cholesterol levels, and markers of metabolic health. Participants also reported enhanced quality of life and reduced weight-related health concerns during treatment. The consistency of these findings across multiple studies has made semaglutide a cornerstone of evidence-based weight management protocols in clinical practice.

Semaglutide Injection vs. Oral Tablets: Which Delivery Method Works Better

PlexusDx offers both injectable and oral semaglutide formulations, allowing patients to choose the delivery method that fits their lifestyle and preferences. Injectable semaglutide is administered once weekly as a subcutaneous injection, typically in the abdomen, thigh, or upper arm. Oral semaglutide requires daily dosing and must be taken on an empty stomach 30 minutes before food or other medications to ensure proper absorption.

Clinical data indicates that injectable semaglutide produces slightly higher average weight loss compared to the oral form, though individual response varies considerably. Injectable formulations achieve more consistent blood levels due to weekly dosing schedules, while oral tablets depend on daily compliance and proper timing relative to meals. Both delivery methods are compounded in licensed 503A pharmacies and available through PlexusDx at $189/mo month-to-month, or from $149/mo on the 6-month plan for injections and $289 monthly for oral tablets.

Personalized Weight Loss: The Role of Genetic Testing in Semaglutide Response

Not everyone responds identically to semaglutide because genetic variations influence how your body processes appetite signals and metabolic hormones. PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway assessment that examines key genetic variants including GIPR rs1800437, and MC4R rs17782313—all known to affect semaglutide responsiveness and weight loss outcomes. This $298 test, maps 14 distinct metabolic pathways and provides insights into which peptide-based therapies may work best for your individual biology.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Important Considerations and Potential Side Effects

The most commonly reported side effects of semaglutide are gastrointestinal in nature and typically occur during the initial weeks of treatment or when doses increase. Nausea, constipation, and mild diarrhea affect a significant percentage of users, though these symptoms frequently diminish as your body adjusts. Slower dose escalation—beginning with lower starting doses and advancing gradually—reduces the likelihood and severity of gastrointestinal upset.

Semaglutide is not appropriate for everyone and should not be used by individuals with a personal or family history of thyroid cancer or multiple endocrine neoplasia type 2 (MEN2). Pregnant individuals or those planning pregnancy should discontinue the medication, as animal studies have raised safety concerns. PlexusDx providers conduct thorough health screenings before initiating treatment to ensure semaglutide is a safe and appropriate choice for each individual patient.

Cost and Access: Getting Semaglutide Without Insurance

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across three commitment tiers, with your dose able to increase while your price remains stable—meaning higher doses don't cost more. The oral formulation begins at $249 monthly. Both formulations are sourced exclusively from licensed 503A compounding pharmacies, ensuring pharmaceutical quality without requiring insurance approval or membership fees.

All PlexusDx medications are HSA and FSA eligible, allowing you to use pre-tax healthcare savings to cover treatment costs. Patients in all 50 states can access these medications, and PlexusDx operates without insurance requirements, making weight loss treatment available regardless of your coverage status. After your first month of therapy, the optional Precision Peptide Genetic Test ($298) can provide additional personalization guidance for your ongoing treatment plan.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long does semaglutide take to show weight loss results?

Most people begin noticing reduced appetite within days to weeks of starting semaglutide, though measurable weight loss typically appears after 4-8 weeks of consistent use. The STEP trials documented progressive weight loss over 68 weeks, with the most dramatic changes occurring between weeks 12 and 32.

Can I stop taking semaglutide once I reach my weight loss goal?

Most people regain significant weight after discontinuing semaglutide because the underlying metabolic and hormonal factors that created obesity remain present. Clinical data shows that maintaining treatment is necessary to sustain weight loss results long-term.

Is compounded semaglutide as effective as brand-name Ozempic?

PlexusDx compounded semaglutide is formulated in licensed 503A pharmacies using the same active pharmaceutical ingredient as brand medications, following strict quality and potency standards.

What makes PlexusDx semaglutide affordable compared to other providers?

PlexusDx eliminates insurance intermediaries, membership fees, and unnecessary markup by sourcing directly from licensed 503A compounding pharmacies and passing savings to patients. Pricing is $189/mo month-to-month, or from $149/mo on the 6-month plan with no dose-based surcharges, and treatment is accessible without insurance in all 50 states.

How does the Precision Peptide Genetic Test improve my semaglutide results?

The Precision Peptide Genetic Test identifies variations in genes like MC4R that directly influence your appetite regulation and weight loss response to semaglutide.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.